Microbial metabolite could boost efficacy of immunotherapy in pancreatic cancer
A gut microbial metabolite called trimethylamine N-oxide, or TMAO, could improve immunotherapy success in pancreatic cancer.
Microbial metabolite could boost efficacy of immunotherapy in pancreatic cancer
A gut microbial metabolite called trimethylamine N-oxide, or TMAO, could improve immunotherapy success in pancreatic cancer.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
